SDL Lung Cancer Flashcards

1
Q

What are some risk factors for lung cancer?

A

Smoking
Age
Asbestos exposure (mesothelioma - pleural disease)
Radiation exposure
Occupational/environmental pollution (NOTE coal dust is NOT a risk factor) tar and nickel are
Family and genetic factors
Underlying lung pathology such as COPD or ILD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the key symptoms of lung cancer?

A

General: weight loss, fatigue, lymphadenopathy, loss of appetite.
Specific to lung cancer: wheeze, chest pain, cough (non-productive), pleural effusion, SOB, dyspnoea, heamoptysis, finger clubbing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some more syndrome symptoms that may occur in lung cancer?

A

Obstruction of SVC – Pemberton’s signs – raising hands over the head causes facial congestion and cyanosis - medical emergency
Pancost tumour – compression on brachial plexus – cause shoulder/arm pain, weakness/atrophy of mucles on ipsilater side on upper arm + Horners syndrome (apical lung cancer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some complications of lung cancer?

A

Lobal collapse
Secondary spontaneous pneumthorax
Pleural effusion
Pericardial effusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What investigations should be done for suspected lung cancer?

A

Bedside: obs
Bloods: FBC, LFTs, U&Es, CRP, (positive signs of cancer include: Anemia, leukocytosis, thrombocytosis, and hypercoagulable state)
Imaging: High resolution contrast CT (stage and management), CXR - typically initial to screen.
Other: Pulmonary lung function tests (baseline features)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the gold standard diagnostic tests for lung cancer?

A

lung biopsy and histopathology for diagnosis – commonly CT guided percutenaous or endobronchial ultrasound-guided transbronchial needle aspiration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the NICE recommendation relating to CXR for suspected lung cancer?

A

Recommoned a CXR within 2w for 40yrs+ with clubbing, lymphadenopathy (Particularly supraclavicular), recurrent or persistent chest infections, thrombocytosis and chest signs of lung cancer.
If 2+ unexplained symptoms in over40yrs never smoked
if 1+ unexplained symptoms in over 40yrs who have ever smoking or asbestos exposure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is mesothelioma?

A

Cancer of the pleura/ other mesothelial tissue
Related to asbestos exposure
Poor prognosis - chemotherapy can improve outcomes but it is typically palliative.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the two main histological categories of lung cancer?

A

Small cell lung cancer
Non-small cell lung cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give an overview of small cell lung cancer

A

15% of cases, 60% of which present with metastasis, poor prognosis, tends to be a proximal tumor near hilum (larger airways disease), includes neuroendocrine cells – strongest association with smoking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the different types of non small cell lung cancer?

A

Adenocarcinoma (which involves glands in peripheral tissue) - commonly seen in non-smokers.
Squamous cell carcinoma (near main bronchus obstruct airway, cause dysplasia, affects sqaoumous cells - natural or metaplastic )
Large cell (rapidly growing presents in periphery or central lung tissue) - effects epithelial cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Compare the prognosis of NSCLC and SCLC**

A

SCLC - worse prognosis, very few diagnosed in stage 1/2, at stage 3/4 prognosis is roughly half that of NSCLC
NSCLS - better prognosis, more likely to be diagnosed at an earlier stage (although the majority still in stage 3/4)

For both combined - five yrs survival under 15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Compare the risk factors for NSCLC and SCLC.**

A

Smoking and genetics increases the risk of both. However chronic heavy smokers are at a higher risk of SCLC. Genetics particularly EGFR mutation may have a stronger role in NSCLC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the common sites of metastasis of lung cancer?

A

Brain
Liver
Adrenal Gland
Bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is meant by paraneoplastic syndrome in lung cancer?

A

From small cell or squamous cell – often due to hormonal effects, ectopic crushing syndrome, inc ADH (water retention), inc parathyroid like substance (hypercalcemia), Lambert-Eaton myasthenic syndrome – antibodies against small cell lung cancer also target and damage VGCa2+Channels in presynaptic terminals in motor neurons leads to muscle weakness, particularly in the proximal muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the different stages of lung cancer?

A

Stage 1: no bigger than 4cm, not spread to lymph nodes or metastatic
Stage 2: Greater than 4cm. May have spread to nearby lymph nodes (single).
Stage 3: Large tumour (6cm) spread to nearby lymph nodes, or spreading to lymph nodes further away in the chest
Stage 4: Spead to lung on other side, pleura, or other parts of the body such as liver, brain or brain (metastatic)

17
Q

What is the typical treatment for NSCLC?

A

Surgical resection (lobectomy) first line if stage 1 or 2 and medically fit.
Followed by adjuvant chemo if complete resection or radiotherapy if incomplete resection, this surgical regime is often curative.
Radiotherapy for stages 1-3 is not suitable for surgery, chemo may be offered to stage 3 or 4 to improve quality of life (agents include: docetaxel, paclitaxel, gemcitabine) .

18
Q

What is the typical treatment for small cell lung cancer?

A

Often surgery not applicable as late stage disease, typically use cisplatin based combination chemotherapy. Very chemosensitive +/ - radiotherapy.